[PRESS RELEASE] – TALLAHASSEE, Fla., Jan. 29, 2026 – Trulieve Cannabis Corp., a leading and top-performing cannabis company in the U.S., announced that, further to its Dec. 17, 2025 news release, it has closed a second tranche of its previously announced private placement of 10.5% senior secured notes due 2030 in the principal amount of US$60 million (the "offering").
Together with the first offering of notes, which closed on Dec. 17, 2025, Trulieve has issued notes in the aggregate principal amount of US$200 million. The notes were issued at a price of US$1,000 plus accrued but unpaid interest from Dec. 17, 2025, to Jan. 29, 2026, in the amount of US$12.37 per US$1,000 principal of notes, and have the same terms as those issued on Dec. 17, 2025.
The offering was conducted on a "best-efforts" basis pursuant to the terms of an agency agreement between the company and Canaccord Genuity Corp., as sole agent and sole bookrunner. The company will make the required filings to list the notes on the Canadian Securities Exchange (CSE) following the expiry of the four-month Canadian statutory hold period.
The company intends to use the net proceeds of the offering for capital expenditures and other general corporate purposes.
The offering and sale of the notes have not been and will not be registered under the Securities Act of 1933, as amended (the "Securities Act"), or the laws of any other jurisdiction.
This news release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of the notes in any state or jurisdiction in which such offer, solicitation or sale would be unlawful.
